BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 12780430)

  • 1. Triage by HPV-DNA testing: is it useful in women with persistent minor smear abnormalities?
    Pisal N; Sindos M; Chow C; Singer A
    Acta Obstet Gynecol Scand; 2003 Jun; 82(6):575-7. PubMed ID: 12780430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study.
    Kelly RS; Patnick J; Kitchener HC; Moss SM;
    Br J Cancer; 2011 Sep; 105(7):983-8. PubMed ID: 21897395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV testing in primary screening of older women.
    Cuzick J; Beverley E; Ho L; Terry G; Sapper H; Mielzynska I; Lorincz A; Chan WK; Krausz T; Soutter P
    Br J Cancer; 1999 Oct; 81(3):554-8. PubMed ID: 10507785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Human papillomavirus typing in routine cervical smears. Results from a series of 3778 patients].
    Levert M; Clavel C; Graesslin O; Masure M; Birembaut P; Quereux C; Gabriel R
    Gynecol Obstet Fertil; 2000 Oct; 28(10):722-8. PubMed ID: 11244634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between integration of high-risk HPV genome into human DNA detected by molecular combing and the severity of cervical lesions: first results of the EXPL-HPV-002 study.
    Bouchilloux S; Fer F; Lemée F; Barradeau S; Dvorak V; Kubickova S; Ventruba P; Tachezy R; Trnková M; Janda P; Abscheidt J; Annibal E; El Mhali D; Garcia F; Kech M; Pilger G; Bensimon A; Mahé F
    Ceska Gynekol; 2019; 84(2):84-92. PubMed ID: 31238677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus testing for triage of women referred because of abnormal smears. a decision analysis considering outcomes and costs.
    Meerding WJ; van Ballegooijen M; Burger MP; van den Akker-van Marle ME; Quint WG; Habbema JD
    J Clin Epidemiol; 2002 Oct; 55(10):1025-32. PubMed ID: 12464379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High performance of combined HPV testing and genotyping for HPV16/18/52/58 in triaging women with minor cervical cytological abnormalities in northern Thailand.
    Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Intaraphet S; Siriaunkgul S
    J Med Virol; 2016 Jan; 88(1):135-43. PubMed ID: 26129775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears.
    Zielinski GD; Snijders PJ; Rozendaal L; Voorhorst FJ; van der Linden HC; Runsink AP; de Schipper FA; Meijer CJ
    Br J Cancer; 2001 Aug; 85(3):398-404. PubMed ID: 11487272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of human papillomavirus DNA in patients referred to a family practice colposcopy clinic.
    Holman JR
    J Am Board Fam Pract; 1996; 9(3):162-6. PubMed ID: 8743228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study.
    Chatzistamatiou K; Moysiadis T; Angelis E; Kaufmann A; Skenderi A; Jansen-Duerr P; Lekka I; Kilintzis V; Angelidou S; Katsiki E; Hagemann I; Tsertanidou A; Koch I; Boecher O; Soutschek E; Maglaveras N; Agorastos T
    Arch Gynecol Obstet; 2017 May; 295(5):1247-1257. PubMed ID: 28337594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of adjunctive HPV testing by Hybrid Capture II in women with minor cytological abnormalities for the diagnosis of CIN2/3 and cost comparison with colposcopy.
    Guyot A; Karim S; Kyi MS; Fox J
    BMC Infect Dis; 2003 Sep; 3():23. PubMed ID: 14511396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triage using HPV-testing in persistent borderline and mildly dyskaryotic smears: proposal for new guidelines.
    Bais AG; Rebolj M; Snijders PJ; de Schipper FA; van der Meulen DA; Verheijen RH; Voorhorst F; van Ballegooijen M; Meijer CJ; Helmerhorst TJ
    Int J Cancer; 2005 Aug; 116(1):122-9. PubMed ID: 15751045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of human papillomavirus 16/18 oncoprotein test for cervical cancer screening and HPV positive women triage.
    Yu L; Jiang M; Qu P; Wu Z; Sun P; Xi M; Qin Y; Liu X; Liao G; Lei X; Sun L; Zhang Y; Li Z; Chen W; Qiao YL
    Int J Cancer; 2018 Aug; 143(4):813-822. PubMed ID: 29524206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative detection of oncogenic HPV DNA using hybrid capture to triage borderline and mildly dyskaryotic Papanicolaou smears.
    Mould TA; Singer A; Gallivan S
    Eur J Gynaecol Oncol; 2000; 21(3):245-8. PubMed ID: 10949385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Study of Cytology and Histopathology of Cervical Lesion in VIA Positive Patients and Its Correlation with High Risk Human Papilloma Virus.
    Ansari NP; Saleh FM; Shahida SM; Rahman EN
    Mymensingh Med J; 2017 Jul; 26(3):505-513. PubMed ID: 28919602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus testing in young women: clinical outcomes of human papillomavirus triage in a UK cervical screening program.
    McKenna M; McMenamin MM
    Cancer Cytopathol; 2014 Sep; 122(9):702-10. PubMed ID: 24888573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with human papillomavirus infection in women encountered in community-based offices.
    Reed BD; Zazove P; Gregoire L; Gorenflo DW; Lancaster WD; Ruffin MT
    Arch Fam Med; 1993 Dec; 2(12):1239-48. PubMed ID: 8130905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between colposcopic, cytologic, and histologic findings in women positive and negative for human papillomavirus DNA.
    Moscicki AB; Broering J; Powell K; Klein J; Clayton L; Smith G; Boero S; Darragh TM; Brescia RJ; Palefsky J
    J Adolesc Health; 1993 Mar; 14(2):74-9. PubMed ID: 8386548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The planning of cervical cancer screening programmes in eastern Europe: is viral testing a suitable alternative to smear testing?
    Sherlaw-Johnson C; Gallivan S
    Health Care Manag Sci; 2000 Sep; 3(4):323-9. PubMed ID: 11105418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosocial outcomes of three triage methods for the management of borderline abnormal cervical smears: an open randomised trial.
    McCaffery KJ; Irwig L; Turner R; Chan SF; Macaskill P; Lewicka M; Clarke J; Weisberg E; Barratt A
    BMJ; 2010 Feb; 340():b4491. PubMed ID: 20179125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.